Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

AAN: New Guideline on Disease-Modifying Therapies for MS Published

By Apr 24, 2018

The guideline, published in the journal Neurology, provides recommendations on initiating, switching, and discontinuing DMTs relevant to patients with relapsing-remitting MS (RRMS), secondary progressive MS, primary progressive MS (PPMS), and clinically isolated syndromes of demyelination.

Trelegy Ellipta Gains Expanded COPD Indication, Loses Boxed Warning

By Apr 24, 2018

The drug consists of fluticasone furoate, an inhaled corticosteroid (ICS), umeclidinium, a long-acting muscarinic antagonist, and vilanterol, a long-acting beta2-adrenergic agonist (LABA), delivered via an Ellipta dry powder inhaler.

Exposure to Anti-TNF Therapy Linked to Reduced Parkinson's Disease Risk

By Apr 24, 2018

Previous research has suggested a genetic and functional link between IBD and PD, however evidence regarding this association has been limited.

CDC: Recommendations on the Use of Heplisav-B Published

By Apr 23, 2018

Benefits of protection with 2 doses administered over 1 month make the vaccine an important option for prevention of HBV.

First Test to ID <i>Candida auris</i> Gets FDA Approval

By Apr 23, 2018

The Bruker Maldi system is already cleared for use in identifying 333 species or species groups, including 424 bacteria and yeast species.

More Articles by Da Hee Han, PharmD